Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Carparts.Com Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Carparts.Com Inc trades at $8.63 (market cap $66.42M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 189.4× Carparts.Com Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Carparts.Com Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Carparts.Com Inc for 45 Days on average.
| HALO | PRTS | |
|---|---|---|
Market Cap | $12.58B | $66.42M |
Volume | 2,179,278 | 40,287 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $10.00 |
52-Week Low | $61.63 | $3.88 |
Typical Hold Time | 1 Days | 45 Days |
Enterprise Value | $14.49B | $79.39M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarParts.com (PRTS) trades at $8.64, down 0.63% on the day, with a bullish technical signal from moving averages. The company shows improving quarterly earnings performance, beating estimates for three consecutive quarters despite negative net income margins. Revenue has declined from $676M in 2023 to $548M in 2025, but recent news highlights the company's focus on leveraging proprietary data to build competitive advantages in the automotive e-commerce space.
While analyst sentiment remains positive with 60% buy ratings, the stock faces fundamental challenges including declining revenue, negative profitability metrics, and negative operating cash flow. The primary investment opportunity lies in the company's improving earnings trajectory and data-driven strategy, balanced against execution risks in a competitive market and ongoing profitability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
